Literature DB >> 12361240

A compartmental model of hepatic disposition kinetics: 1. Model development and application to linear kinetics.

Yuri G Anissimov1, Michael S Roberts.   

Abstract

The conventional convection-dispersion model is widely used to interrelate hepatic availability (F) and clearance (Cl) with the morphology and physiology of the liver and to predict effects such as changes in liver bloodflow on F and Cl. The extension of this model to include nonlinear kinetics and zonal heterogeneity of the liver is not straightforward and requires numerical solution of partial differential equation, which is not available in standard nonlinear regression analysis software. In this paper, we describe an alternative compartmental model representation of hepatic disposition (including elimination). The model allows the use of standard software for data analysis and accurately describes the outflow concentration-time profile for a vascular marker after bolus injection into the liver. In an evaluation of a number of different compartmental models, the most accurate model required eight vascular compartments, two of them with back mixing. In addition, the model includes two adjacent secondary vascular compartments to describe the tail section of the concentration-time profile for a reference marker. The model has the added flexibility of being easy to modify to model various enzyme distributions and nonlinear elimination. Model predictions of F, MTT, CV2, and concentration-time profile as well as parameter estimates for experimental data of an eliminated solute (palmitate) are comparable to those for the extended convection-dispersion model.

Entities:  

Mesh:

Year:  2002        PMID: 12361240     DOI: 10.1023/a:1019703607647

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  37 in total

1.  Interconnected-tubes model of hepatic elimination: steady-state considerations.

Authors:  Y G Anissimov; A J Bracken; M S Roberts
Journal:  J Theor Biol       Date:  1999-08-21       Impact factor: 2.691

Review 2.  Enterohepatic circulation: physiological, pharmacokinetic and clinical implications.

Authors:  Michael S Roberts; Beatrice M Magnusson; Frank J Burczynski; Michael Weiss
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

3.  Analysis of nonlinear hepatic clearance of a cyclopentapeptide, BQ-123, with the multiple indicator dilution method using the dispersion model.

Authors:  A Hisaka; T Nakamura; Y Sugiyama
Journal:  Pharm Res       Date:  1999-01       Impact factor: 4.200

4.  Application of the dispersion model for description of the outflow dilution profiles of noneliminated reference indicators in rat liver perfusion studies.

Authors:  A J Schwab; W Geng; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1998-04

5.  Interconnected-tubes model of hepatic elimination.

Authors:  Y G Anissimov; A J Bracken; M S Roberts
Journal:  J Theor Biol       Date:  1997-09-07       Impact factor: 2.691

6.  A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerations.

Authors:  M S Roberts; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1986-06

7.  Convection-dispersion modeling of hepatic elimination.

Authors:  L Bass
Journal:  J Pharm Sci       Date:  1986-03       Impact factor: 3.534

8.  Cytoplasmic binding and disposition kinetics of diclofenac in the isolated perfused rat liver.

Authors:  M Weiss; O Kuhlmann; D Y Hung; M S Roberts
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

9.  Effect of fasting on the uptake of bilirubin and sulfobromophthalein by the isolated perfused rat liver.

Authors:  U Gärtner; T Goeser; A W Wolkoff
Journal:  Gastroenterology       Date:  1997-11       Impact factor: 22.682

10.  A new method for quantitating intracellular transport: application to the thyroid hormone 3,5,3'-triiodothyronine.

Authors:  B A Luxon; R A Weisiger
Journal:  Am J Physiol       Date:  1992-11
View more
  7 in total

1.  An improved nonlinear model describing the hepatic pharmacokinetics of digoxin: evidence for two functionally different uptake systems and saturable binding.

Authors:  Michael Weiss; Peng Li; Michael S Roberts
Journal:  Pharm Res       Date:  2010-07-13       Impact factor: 4.200

2.  Modeling and simulation of hepatic drug disposition using a physiologically based, multi-agent in silico liver.

Authors:  Li Yan; Glen E P Ropella; Sunwoo Park; Michael S Roberts; C Anthony Hunt
Journal:  Pharm Res       Date:  2007-11-28       Impact factor: 4.200

3.  Tissue-level modeling of xenobiotic metabolism in liver: An emerging tool for enabling clinical translational research.

Authors:  Marianthi G Lerapetritou; Panos G Georgopoulos; Charles M Roth; Loannis P Androulakis
Journal:  Clin Transl Sci       Date:  2009-06       Impact factor: 4.689

Review 4.  Drug structure-transport relationships.

Authors:  Michael S Roberts
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-11-24       Impact factor: 2.745

5.  A Computational Model of Hepatic Energy Metabolism: Understanding Zonated Damage and Steatosis in NAFLD.

Authors:  William B Ashworth; Nathan A Davies; I David L Bogle
Journal:  PLoS Comput Biol       Date:  2016-09-15       Impact factor: 4.475

6.  A multiscale modelling approach to assess the impact of metabolic zonation and microperfusion on the hepatic carbohydrate metabolism.

Authors:  Nikolaus Berndt; Marius Stefan Horger; Sascha Bulik; Hermann-Georg Holzhütter
Journal:  PLoS Comput Biol       Date:  2018-02-15       Impact factor: 4.475

7.  Representative Sinusoids for Hepatic Four-Scale Pharmacokinetics Simulations.

Authors:  Lars Ole Schwen; Arne Schenk; Clemens Kreutz; Jens Timmer; María Matilde Bartolomé Rodríguez; Lars Kuepfer; Tobias Preusser
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.